Previous 10 | Next 10 |
The FDA grants 510(k) clearance to Anika Therapeutics' (ANIK) WristMotion Total Arthroplasty System for the replacement of the wrist joint due to rheumatoid arthritis, osteoarthritis, or post-traumatic arthritis.The event triggers a $5M milestone payment to former equity holders of Arthrosurf...
BEDFORD, Mass., Oct. 21, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care, today announced that the Company’s WristMotion Total Arthroplast...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...
Presentation Times and Weblinks Released for Over 150 Presenting Companies Day 2: Thursday, September 24, 2020 ALL INSTITUTIONAL AND RETAIL INVESTORS ARE WELCOME NEW YORK, NY / ACCESSWIRE / September 23, 2020 / Sidoti & Company, LLC has released the presentation schedule, ...
BEDFORD, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation, restoration and regenerative solutions company with products across the orthopedic early intervention continuum of care, today announced that Cheryl R. Bl...
Quick Take InMode ( INMD ) went public in August, 2019, selling five million shares at $14.00 to collect $70 million in gross proceeds. The firm has been commercializing its adipose fat tissue remodeling technologies. INMD has managed its business through the Covid-19 pandemic for long...
BEDFORD, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation, restoration and regenerative solutions company with products across the orthopedic early intervention continuum of care, today announced the appointment of...
Anika Therapeutics, Inc. (ANIK) Q2 2020 Earnings Conference Call July 30, 2020 5:00 PM ET Company Participants Kristen Galfetti - Investor Relations Cheryl Blanchard - President and Chief Executive Officer Sylvia Cheung - Chief Financial Officer Conference Call Participants ...
Investment Thesis Anika Therapeutics 5-year share price performance. Source: TradingView Anika Therapeutics' ( ANIK ) share price has dealt in peaks and troughs over the past couple of years after a 5-year period of exceptional growth - the stock grew by 2000% between 2013 and 2018. A ...
The following slide deck was published by Anika Therapeutics, Inc. in conjunction with their 2020 Q2 earnings Read more ...
News, Short Squeeze, Breakout and More Instantly...
Anika Therapeutics Inc. Company Name:
ANIK Stock Symbol:
NASDAQ Market:
Anika Therapeutics Inc. Website:
Integrity and its complete arthroscopic instrumentation platform are now fully available in the U.S., expanding Anika’s proprietary hyaluronic acid (HA) regenerative portfolio Over 300 surgeries completed during the limited market release, highlighting the growing interest and commerci...
2024-07-09 17:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-29 13:30:02 ET Stephens analyst issues EQUAL-WEIGHT recommendation for ANIK on May 29, 2024 12:00PM ET. The previous analyst recommendation was Equal-Weight. ANIK was trading at $25.32 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...